Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new medicines set out in the Schedule hereto:
Schedule
Product: Citalopram - Rex
Active Ingredient: Citalopram hydrobromide 12.495mg equivalent to citalopram 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Manufacturing Division, MIDC Industrial Area, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India
Product: Citalopram - Rex
Active Ingredient: Citalopram hydrobromide 24.99mg equivalent to citalopram 20mg
Dosage Form: Film coated tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Manufacturing Division, MIDC Industrial Area, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India
Product: Citalopram - Rex
Active Ingredient: Citalopram hydrobromide 49.98mg equivalent to citalopram 40mg
Dosage Form: Film coated tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Manufacturing Division, MIDC Industrial Area, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India
Product: Combigan
Active Ingredients: Brimonidine tartrate 2mg/mL
Timolol maleate 6.8mg/mL equivalent to timolol base 5mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Pharmaceuticals Ireland, Westport, County Mayo, Ireland
Product: Emtriva
Active Ingredient: Emtricitabine 200mg
Dosage Form: Capsule
New Zealand Sponsor: Muir Hutchison Limited
Manufacturer: Abbott Laboratories Inc, Abbott Park, Illinois, United States of America
Product: Flonazol
Active Ingredient: Fluconazole 150mg
Dosage Form: Capsule
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Pharmathen SA, Pallini, Attikis, Greece
Dated this 20th day of October 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).